ストックスクリーナーアプリを入手
5.63
1.83%
-0.10
アフターアワーズ：
5.60
-0.03
-0.53%
前日終値:
$5.73
開ける：
$5.75
24時間の取引高:
2.08M
Relative Volume:
0.82
時価総額：
$2.09B
収益：
$9.47B
当期純損益:
$-178.00M
株価収益率:
-11.73
EPS:
-0.48
ネットキャッシュフロー:
$1.01B
1週間 パフォーマンス:
-7.94%
1か月 パフォーマンス:
-0.62%
6か月 パフォーマンス:
-21.98%
1年 パフォーマンス:
-19.76%
1日の値動き範囲:
$5.565
$5.77
1週間の範囲:
$5.565
$6.095
52週間の値動き範囲:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
名前
Bausch Health Companies Inc
セクター
電話
514-744-6792
住所
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
5.63 | 2.12B | 9.47B | -178.00M | 1.01B | -0.48 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2024-08-02 | ダウングレード | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 開始されました | Raymond James | Mkt Perform |
| 2023-09-20 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | ダウングレード | Truist | Buy → Hold |
| 2022-07-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 再開されました | JP Morgan | Overweight |
| 2021-03-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-02-17 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-24 | 開始されました | Citigroup | Buy |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 開始されました | Goldman | Neutral |
| 2019-10-25 | 開始されました | Cowen | Outperform |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-08-15 | アップグレード | TD Securities | Hold → Buy |
| 2019-07-19 | 開始されました | Wolfe Research | Outperform |
| 2019-06-11 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2019-01-02 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | アップグレード | Piper Jaffray | Underweight → Neutral |
すべてを表示
Bausch Health Companies Inc (BHC) 最新ニュース
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com UK
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health (NYSE: BHC) CEO granted 815K RSUs, 116K shares withheld for tax - Stock Titan
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire
New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan
Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com
Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Can Bausch Health Companies Inc expand into new markets2025 Trade Ideas & Weekly Sector Rotation Insights - baoquankhu1.vn
Bausch Health revenue by segment 2021-2024 - Statista
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz
Bausch Health Cos (NYSE:BHC) Shares Gap DownTime to Sell? - MarketBeat
How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha
Bausch Health Companies Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - Yahoo Finance
Will Bausch Health Companies Inc announce a stock splitQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Bausch Health Companies Inc (BHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
A Look At Bausch Health Companies (BHC) Valuation After Mixed Quarterly Results And China Expansion - Sahm
Bausch Health (BHC) Q4 2025 Earnings Transcript - The Globe and Mail
Bausch Health Cos Q4 Earnings Call Highlights - Yahoo Finance
Bausch Health (BHC) Q4 Earnings Lag Estimates - Yahoo Finance
Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings - Nasdaq
Bausch: Q4 Earnings Snapshot - kens5.com
Bausch Health Cos (NYSE:BHC) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Bausch Health Companies Inc (BHC) 財務データ
収益
当期純利益
現金流量
EPS
0.18%
1.85%
大文字化:
|
ボリューム (24 時間):